Reprogramming of cancer metabolism is a newly recognized hallmark of malignancy. The aberrant glucose metabolism is associated with dramatically increased bioenergetics, biosynthetic, and redox demands, which is vital to maintain rapid cell proliferation, tumor progression, and resistance to chemotherapy and radiation. When the glucose metabolism of cancer is rewiring, the characters of cancer will also occur corresponding changes to regulate the chemo- and radio-resistance of cancer. The procedure is involved in the alteration of many activities, such as the aberrant DNA repairing, enhanced autophagy, oxygen-deficient environment, and increasing exosomes secretions, etc. Targeting altered metabolic pathways related with the glucose metabolism has become a promising anti-cancer strategy. This review summarizes recent progress in our understanding of glucose metabolism in chemo- and radio-resistance malignancy, and highlights potential molecular targets and their inhibitors for cancer treatment.
机构:
Harvard Med Sch, Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02215 USA
Harvard Med Sch, Brigham Womens Hosp, Boston, MA 02215 USA
CNR, Inst Mol Genet, Via Abbiategrasso 207, I-27100 Pavia, ItalyUniv Milan, I-20122 Milan, Italy
机构:
Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Wu, Yue
Lu, Ruijie
论文数: 0引用数: 0
h-index: 0
机构:
Wenzhou Med Univ, Clin Med Coll 2, Wenzhou, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Lu, Ruijie
Lin, Yujie
论文数: 0引用数: 0
h-index: 0
机构:
Wenzhou Med Univ, Clin Med Coll 2, Wenzhou, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Lin, Yujie
Wang, Jinjin
论文数: 0引用数: 0
h-index: 0
机构:
Wenzhou Med Univ, Clin Med Coll 2, Wenzhou, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Wang, Jinjin
Lou, Zijian
论文数: 0引用数: 0
h-index: 0
机构:
Wenzhou Med Univ, Clin Med Coll 2, Wenzhou, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Lou, Zijian
Zheng, Xiaochun
论文数: 0引用数: 0
h-index: 0
机构:
Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Zheng, Xiaochun
Zhang, Ling
论文数: 0引用数: 0
h-index: 0
机构:
Inst Cell Based Drug Dev Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China
Key Lab Cell Based Drug, Appl Technol Dev Zhejiang Prov, Hangzhou, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Zhang, Ling
Pan, Ruolang
论文数: 0引用数: 0
h-index: 0
机构:
Inst Cell Based Drug Dev Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China
Key Lab Cell Based Drug, Appl Technol Dev Zhejiang Prov, Hangzhou, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Pan, Ruolang
Lu, Gang
论文数: 0引用数: 0
h-index: 0
机构:
Key Lab Cell Based Drug, Appl Technol Dev Zhejiang Prov, Hangzhou, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China
Lu, Gang
Fang, Qingxia
论文数: 0引用数: 0
h-index: 0
机构:
Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R ChinaZhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Hangzhou Med Coll, Ctr Clin Pharm, Hangzhou 310014, Zhejiang, Peoples R China